Acute-phase proteins as indicators of bacterial infection in patients with cirrhosis

Liver International

Volumn 29, Issue 10, 2009, Pages 1538-1542

  Tsiakalos, Aristotelis ^a   Karatzaferis, Aggelos ^a   Ziakas, Panayiotis ^a   Hatzis, Gregorios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Acute phase proteins; Bacterial infection; Cirrhosis; CRP

Indexed keywords

ACUTE PHASE PROTEIN; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FERRITIN; FIBRINOGEN; HAPTOGLOBIN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; AREA UNDER THE CURVE; ARTICLE; AUTOIMMUNE DISEASE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL PERITONITIS; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY DYSFUNCTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MIXED INFECTION; NONALCOHOLIC FATTY LIVER; PNEUMONIA; PRIMARY BILIARY CIRRHOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; URINARY TRACT INFECTION;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ROC CURVE;

EID: 73349097879     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02088.x     Document Type: Article

References (27)

1. Terg R, Gadano A, Cartier M, et al. Serum creatinine and bilirubin predict renal failure and mortality in patients withspontaneous bacterial peritonitis: a retrospective study. Liver Int 2009; 29: 415-9.
2. Navasa M, Rodes J. Bacterial infections in cirrhosis. Liver Int 2004; 24: 277-80.
3. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005; 17: 27-31.
4. Jepsen P, Vilstrup H, Møller JK, Sørensen H.T. Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis. Hepatogastroenterology 2003; 50: 2133-6.
5. Strauss E, Gomes de Sa Ribeiro Mde F. Bacterial infections associated with hepatic encephalopathy: prevalence and outcome. Ann Hepatol 2003; 2: 41-5.
6. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
7. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997; 181: 257-66.
8. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80.
9. Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-74.
10. Le Moine O, Deviere J, Devaster JM, et al. Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. J Hepatol 1994; 20: 819-24.
11. Volpes R, Van den Oord JJ, De Vos R, Desmet V.J. Hepatic expression of type A and type B receptors for tumor necrosis factor. J Hepatol 1992; 14: 361-9.
12. Meliconi R, Parracino O, Facchini A, et al. Acute phase proteins in chronic and malignant liver diseases. Liver 1988; 8: 65-74.
13. Shiota G, Umeki K, Okano J, Kawasaki H. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases. J Med 1995; 26: 295-308.
14. Koruk M, Taysi S, Savas MC, et al. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis. Turk J Gastroenterol 2003; 14: 12-7.
15. Bell H, Skinningsrud A, Raknerud N, Try K. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Intern Med 1994; 236: 315-22.
16. Mackenzie I, Woodhouse J. C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction. Intens Care Med 2006; 32: 344-51.
17. Friedman AC, Johns T, Levy DW, Rindsberg S, Markle B.M. Cirrhosis, other diffuse diseases, portal hypertension, and vascular diseases. In: Radiology of the Liver, Biliary Tract, Pancreas and Spleen. Baltimore: Williams and Wilkins, 1987; 69-88.
18. Sherlock S, Dooley J. Disease of the liver and biliary system. Oxford: Blackwell, 2002, p. 658.
19. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
20. Wibell L, Evrin PE, Berggard I. Serum 2-microglobulin in renal disease. Nephron 1973; 10: 320-31.
21. Guillen MI, Gomez-Lechon MJ, Nakamura T, Castell J.V. The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6-stimulated genes. Hepatology 1996; 23: 1345-52.
22. Chen SM, Lo GH, Lai KH, et al. Serum and ascitic concentration of C3, C4 and protein in cirrhotic patients with spontaneous bacterial peritonitis. Zhonghua Yi Xue Za Zhi 1994; 54: 87-92.
23. Bota DP, Van Nuffelen M, Zakariah AN, Vincent J.L. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005; 146: 347-51.
24. Park WB, Lee KD, Lee CS, et al. Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis. Diagn Microbiol Infect Dis 2005; 51: 227-30.
25. Dong Q, Wright J.R. Expression of C-reactive protein by alveolar macrophages. J Immunol 1996; 56: 4815-20.
26. Jabs WJ, Logering BA, Gerke P, et al. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 2003; 33: 152-61.
27. Lin ZY, Chuang WL, Dai CY, et al. Clinical application of serum C-reactive protein measurement in the detection of bacterial infection in patients with liver cirrhosis. Kaohsiung J Med Sci 2002; 18: 121-6.